Suchergebnisse
NerdWallet Q2 Earnings Call Highlights
Key Points
- Interested in NerdWallet, Inc.? Here are five stocks we like better.
- Q2 revenue rose 6% year over year to $197 million, driven by personal loans and deposit accounts, while
Novanta Q2 Earnings Call Highlights
Key Points
- Interested in Novanta Inc.? Here are five stocks we like better.
- Novanta delivered strong Q2 performance, with 9% organic sales growth, a 16% increase in adjusted EBITDA, 17%
NN Q2 Earnings Call Highlights
Key Points
- Interested in NN, Inc.? Here are five stocks we like better.
- NN delivered strong second-quarter growth: Sales rose 19% to $128.8 million, while adjusted EBITDA increased 36% to
NewtekOne Q2 Earnings Call Highlights
Key Points
- Interested in NewtekOne, Inc.? Here are five stocks we like better.
- NewtekOne is shifting toward recurring net interest income by retaining more SBA 7(a) and
Nature's Sunshine Products Q2 Earnings Call Highlights
Key Points
- Interested in Nature's Sunshine Products, Inc.? Here are five stocks we like better.
- Record Q2 sales: Nature’s Sunshine reported $117 million in second-quarter net sales, up 2% year
Microvision Q2 Earnings Call Highlights
Key Points
- Interested in Microvision, Inc.? Here are five stocks we like better.
- Revenue and margins improved: MicroVision reported Q2 2026 revenue of $1.5 million, up $1.3 million year over
Maravai LifeSciences Q2 Earnings Call Highlights
Key Points
- Interested in Maravai LifeSciences Holdings, Inc.? Here are five stocks we like better.
- Q2 revenue rose 9% to $51.4 million, led by 12% growth at TriLink and 3% growth at Cygnus
Monster Beverage Q2 Earnings Call Highlights
Key Points
- Interested in Monster Beverage Corporation? Here are five stocks we like better.
- Record Q2 performance: Monster Beverage’s net sales rose 20.2% year over year to $2.54 billion
Outset Medical Q2 Earnings Call Highlights
Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis
Ocugen Q2 Earnings Call Highlights
Ocugen (NASDAQ:OCGN) said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an
OmniAb Q2 Earnings Call Highlights
OmniAb (NASDAQ:OABI) reported higher second-quarter revenue and a narrower net loss as milestone payments from partner programs increased, while the company raised its full-year 2026 revenue and
Nova Q2 Earnings Call Highlights
Nova (NASDAQ:NVMI) reported record second-quarter revenue of $255 million, up 8% sequentially and 16% from a year earlier, as demand
Novavax Q2 Earnings Call Highlights
Novavax (NASDAQ:NVAX) reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in
Natera Q2 Earnings Call Highlights
Natera (NASDAQ:NTRA) reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and
Intellia Therapeutics Q2 Earnings Call Highlights
Intellia Therapeutics (NASDAQ:NTLA) said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase
NETGEAR Q2 Earnings Call Highlights
NETGEAR (NASDAQ:NTGR) reported second-quarter 2026 revenue of $168.6 million, down 1.2% from a year earlier but up 6.1% sequentially, as
NetScout Systems Q1 Earnings Call Highlights
NetScout Systems (NASDAQ:NTCT) reported first-quarter fiscal 2027 revenue growth of 13%, citing demand for its service assurance offerings, government-related orders and contributions from its
Insight Enterprises Q2 Earnings Call Highlights
Insight Enterprises (NASDAQ:NSIT) reported second-quarter results that exceeded its expectations, with broad-based growth in hardware, cloud and
Palladyne AI Q2 Earnings Call Highlights
Palladyne AI (NASDAQ:PDYN) reported second-quarter revenue of $5.8 million, a company record that rose 63% sequentially and 470% from a
PDF Solutions Q2 Earnings Call Highlights
PDF Solutions (NASDAQ:PDFS) reported second-quarter revenue growth of 19% from a year earlier and reaffirmed its expectation for 20% revenue

